These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 177837)

  • 1. [Comparative studies on the reduction of lipids using clofibric acid and clofibrate in hyperlipoproteinemias].
    Schwartzkopff W; Hoffmann H; Kästner W
    Med Welt; 1975 Dec; 26(51):2308-15. PubMed ID: 177837
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparative studies on the cholesterol and triglyceride-lowering effect of alpha-methylthyroxine (Skleronorm) and clofibrate (Regelan) in hyperlipoproteinemias of type IIa/b and IV].
    Jantke J; Schwartzkopff W; Zschiedrich M
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():392-5. PubMed ID: 206057
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of primary hyperlipoproteinemias. Comparison of N 041 with clofibrate].
    Gaertner U; Johannes KJ
    MMW Munch Med Wochenschr; 1976 Sep; 118(36):1127-30. PubMed ID: 184377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of primary hyperlipoproteinemias of type IIB and IV with butylbiguanide and clofibrate (author's transl)].
    Koschinsky T; Gries FA; Schwandt P; Weisweiler P; Hansen W; Nijssen J; Beckmann R
    MMW Munch Med Wochenschr; 1977 May; 119(20):701-4. PubMed ID: 195201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effect of a combination treatment with clofibrate on the lipoprotein pattern of endogenous hypertriglyceridemia].
    Vogelberg KH; Althoff B; Heggen EM; Thesseling W
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 1():832-5. PubMed ID: 196437
    [No Abstract]   [Full Text] [Related]  

  • 6. Clofibrate and related compounds in hyperlipoproteinaemia. A review.
    Gustafson A
    Postgrad Med J; 1975; 51(8):suppl 66-71. PubMed ID: 215983
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical and therapeutic evaluation of a new antilipemic substance].
    de Aguiar Magano L
    Arch Sci Med (Torino); 1980; 137(1):131-9. PubMed ID: 7458646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gemfibrozil treatment: a comparison with clofibrate.
    Howard AN; Ghosh P
    Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):88-9. PubMed ID: 190609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Bezafibrate and delayed action etofibrate in hyperlipidemia].
    Lang PD; Vollmar J
    Dtsch Med Wochenschr; 1983 Feb; 108(8):302-5. PubMed ID: 6825604
    [No Abstract]   [Full Text] [Related]  

  • 10. [Therapy of hyperlipemia and hyperuricemia with a combination of clofibrate and an extractive mucopolysaccharide complex].
    Loizzi P; Terlizzi N
    Reumatismo; 1975; 27(1):157-62. PubMed ID: 184507
    [No Abstract]   [Full Text] [Related]  

  • 11. [Current trends in the therapy of arteriosclerotic disease].
    Toscano S
    G Clin Med; 1974 Jan; 55(1):27-39. PubMed ID: 4369524
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of a new synthetic compound (3-nicotinoyl-oxypropyl p-chlorophenoxy isobutyrate: I.612) on plasma lipids in patients with type IIa, IIb and IV hyperdyslipidemia].
    Bucalossi A; Buzzelli G; D'Alessandro A
    Clin Ter; 1979 Apr; 89(2):127-49. PubMed ID: 226307
    [No Abstract]   [Full Text] [Related]  

  • 13. [Use of miskleron in ischemic heart disease with differing types of hyperlipoproteinemias].
    Krivoruchenko IV; Nikul'cheva NG
    Kardiologiia; 1976 Jul; 16(7):71-5. PubMed ID: 185448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Problems of long-term treatment of hyperlipoproteinemia with clofibrinic acid].
    Hanefeld M; Schulze J; Fritz T; Kemmer C
    Z Gesamte Inn Med; 1973 May; 28(10):Suppl 10:160 c. PubMed ID: 4200340
    [No Abstract]   [Full Text] [Related]  

  • 15. Serum lipoprotein lipids after gemfibrozil treatment.
    Schwandt P; Weisweiler P; Neureuther G
    Artery; 1979 Feb; 5(2):117-24. PubMed ID: 231950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clofibrate action on the lipoprotein composition in primary type IV and type V hyperlipoproteinemia].
    Weisweiler P; Schwandt P
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():398-401. PubMed ID: 206058
    [No Abstract]   [Full Text] [Related]  

  • 17. Bile acid metabolism in hyperlipoproteinaemia.
    Hellström K; Einarsson K
    Clin Gastroenterol; 1977 Jan; 6(1):103-28. PubMed ID: 196796
    [No Abstract]   [Full Text] [Related]  

  • 18. The primary hyperlipoproteinemias.
    Bybee DE; Hamilton RD
    J Ky Med Assoc; 1974 Dec; 72(12):658-62. PubMed ID: 4373515
    [No Abstract]   [Full Text] [Related]  

  • 19. [Comparison of clofibrate and bezafibrate in type IIa and type IIb hyperlipoproteinemia].
    Arntz HR; Klemens UH; Vollmar LJ; Lang PD
    Med Klin; 1978 Dec; 73(49):1731-7. PubMed ID: 723760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Lipoproteins and hyperlipoproteinemias].
    Weisweiler P; Schwandt P
    Fortschr Med; 1980 Mar; 98(9):313-6. PubMed ID: 7372258
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.